Literature DB >> 34267454

Epstein-Barr Virus Expression in Classic Hodgkin Lymphoma in an Indian Cohort and its Association with Clinical and Histomorphological Parameters.

Preeti Rani1, Mili Jain1, Nishant Verma2, Archana Kumar2, Amita Jain3, Anil Kumar Tripathi4, Ashutosh Kumar1.   

Abstract

Epstein Barr virus (EBV) associated Hodgkin lymphoma (HL) has been defined as cases with clonal EBV infection, EBV genome and gene products in the Reed Sternberg cells. We evaluated the prevalence and clinico-pathological association of EBV in North Indian HL patients. Eighty-eight cases of histologically confirmed classic HL were evaluated for EBV by both IHC expression of LMP1 and real time PCR on formalin fixed lymph node tissue. The expression pattern was analyzed for any association with clinical and histomorphological parameters. Nodular sclerosis subtype was seen in 79.5% patients and mixed cellularity was seen in the remaining patients. Ninety percent of the cases were positive for EBV. The detection rate of EBV by IHC was higher. The EBV positive cases presented with higher disease stage (p < 0.05). The presence of histomorphological features like granuloma formation (5/5), atypical lymphocytes (8/8), histiocyte clusters (26/28), large area of necrosis (11/12), less prominent inflammatory response (25/27) was associated with EBV positivity (p > 0.05). In our study population a high proportion of HL cases showed positivity for EBV indicating a pathogenic role. The positivity was independent of age, gender and histological subtype. Further evaluation of EBV positivity in modulation of tumor immunity may provide insights into variable treatment outcome in EBV positive cases. © Indian Society of Hematology and Blood Transfusion 2020.

Entities:  

Keywords:  EBV; Epstein–Barr virus; Hodgkin lymphoma; Mixed cellularity Hodgkin lymphoma; Nodular sclerosis Hodgkin lymphoma

Year:  2020        PMID: 34267454      PMCID: PMC8239083          DOI: 10.1007/s12288-020-01359-9

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.915


  17 in total

1.  Development of a real-time quantitative assay for detection of Epstein-Barr virus.

Authors:  H G Niesters; J van Esser; E Fries; K C Wolthers; J Cornelissen; A D Osterhaus
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Hodgkin's lymphoma: immunohistochemical features and its association with EBV LMP-1. Experience from a South Indian hospital.

Authors:  Swapnil Karnik; Bhuvana Srinivasan; Sheila Nair
Journal:  Pathology       Date:  2003-06       Impact factor: 5.306

Review 3.  Epstein-Barr virus-associated Hodgkin's lymphoma.

Authors:  Maher K Gandhi; Judy T Tellam; Rajiv Khanna
Journal:  Br J Haematol       Date:  2004-05       Impact factor: 6.998

4.  Principles and methods of immunohistochemistry.

Authors:  José A Ramos-Vara
Journal:  Methods Mol Biol       Date:  2011

5.  Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.

Authors:  Maher K Gandhi; Eleanore Lambley; Jacqueline Burrows; Ujjwal Dua; Suzanne Elliott; Peter J Shaw; H Miles Prince; Max Wolf; Kerrie Clarke; Craig Underhill; Tony Mills; Peter Mollee; Devinder Gill; Paula Marlton; John F Seymour; Rajiv Khanna
Journal:  Clin Cancer Res       Date:  2006-01-15       Impact factor: 12.531

6.  Development of novel triplex single-step real-time PCR assay for detection of Hepatitis Virus B and C simultaneously.

Authors:  Shantanu Prakash; Amita Jain; Bhawana Jain
Journal:  Virology       Date:  2016-02-22       Impact factor: 3.616

7.  Comparison of three methods for the detection of Epstein-Barr virus in Hodgkin's lymphoma in paraffin-embedded tissues.

Authors:  Zong-Li Qi; Xi-Qun Han; Jun Hu; Guang-Hua Wang; Jin-Wei Gao; Xin Wang; Dao-Yan Liang
Journal:  Mol Med Rep       Date:  2012-11-01       Impact factor: 2.952

Review 8.  The role of cytokines in classical Hodgkin lymphoma.

Authors:  Brian F Skinnider; Tak W Mak
Journal:  Blood       Date:  2002-06-15       Impact factor: 22.113

9.  Epstein-Barr virus association in classical Hodgkin's disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed-Sternberg cells.

Authors:  K N Naresh; J Johnson; V Srinivas; C S Soman; T Saikia; S H Advani; R A Badwe; K A Dinshaw; M Muckaden; I Magrath; K Bhatia
Journal:  Ann Oncol       Date:  2000-01       Impact factor: 32.976

10.  Plasma Epstein Barr virus (EBV) DNA as a biomarker for EBV associated Hodgkin lymphoma.

Authors:  Veronique Dinand; Anupam Sachdeva; Sanghamitra Datta; Sunita Bhalla; Manas Kalra; Chand Wattal; Nita Radhakrishnan
Journal:  Indian Pediatr       Date:  2015-08       Impact factor: 1.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.